Investigating the role of Kinesin family in lung adenocarcinoma via integrated bioinformatics approach
暂无分享,去创建一个
S. Rashid | Prithvi Singh | Ravins Dohare | K. Dev | A. Alsaiari | Atul Kumar | Leen Alqahtani | M. Hasan | Mohammed Ageeli Hakami | Gulnaz Tabassum | Nada Alkhorayef | Rishabh Gurung
[1] A. Rahmani,et al. Integrative Multiomics and Regulatory Network Analyses Uncovers the Role of OAS3, TRAFD1, miR-222-3p, and miR-125b-5p in Hepatitis E Virus Infection , 2022, Genes.
[2] M. Kanehisa,et al. KEGG for taxonomy-based analysis of pathways and genomes , 2022, Nucleic Acids Res..
[3] Prithvi Singh,et al. miR-495-3p regulates sphingolipid metabolic reprogramming to induce Sphk1/ceramide mediated mitophagy and apoptosis in NSCLC. , 2022, Free Radical Biology & Medicine.
[4] Kang Zhang,et al. Integrated single-cell RNA sequencing analysis reveals distinct cellular and transcriptional modules associated with survival in lung cancer , 2022, Signal Transduction and Targeted Therapy.
[5] A. Lánczky,et al. Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation , 2021, Journal of medical Internet research.
[6] Zhaodong Li,et al. KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung Adenocarcinoma , 2021, Frontiers in Oncology.
[7] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[8] Hui Li,et al. Identification of KIF4A and its effect on the progression of lung adenocarcinoma based on the bioinformatics analysis , 2021, Bioscience reports.
[9] Jian-Hua Fu,et al. Identification of activated pathways in lung adenocarcinoma based on network strategy , 2020, Journal of cancer research and therapeutics.
[10] Xiaole Shirley Liu,et al. TIMER2.0 for analysis of tumor-infiltrating immune cells , 2020, Nucleic Acids Res..
[11] Yiyan Lei,et al. Combined evaluation of the expression status of CD155 and TIGIT plays an important role in the prognosis of LUAD (lung adenocarcinoma). , 2020, International immunopharmacology.
[12] Jin-hai Tang,et al. Kinesin family member 15 promotes cancer stem cell phenotype and malignancy via reactive oxygen species imbalance in hepatocellular carcinoma. , 2019, Cancer letters.
[13] Minoru Kanehisa,et al. Toward understanding the origin and evolution of cellular organisms , 2019, Protein science : a publication of the Protein Society.
[14] Yifang Zhou,et al. Clinical Significance And Integrative Analysis Of Kinesin Family Member 18B In Lung Adenocarcinoma , 2019, OncoTargets and therapy.
[15] D. Xie,et al. Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial–mesenchymal transition via Akt/GSK3β signaling , 2019, Cancer science.
[16] F. Grossi,et al. Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds , 2019, Expert opinion on investigational drugs.
[17] Erin L. Schenk,et al. Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer , 2019, Front. Immunol..
[18] D. Mochly‐Rosen,et al. Targeting mitochondrial dysfunction and oxidative stress in heart failure: Challenges and opportunities , 2018, Free radical biology & medicine.
[19] Damian Szklarczyk,et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..
[20] Yuan Qiao,et al. Increased KIF15 Expression Predicts a Poor Prognosis in Patients with Lung Adenocarcinoma , 2018, Cellular Physiology and Biochemistry.
[21] Q. Ye,et al. Overexpression of KIF2A is Suppressed by miR-206 and Associated with Poor Prognosis in Ovarian Cancer , 2018, Cellular Physiology and Biochemistry.
[22] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[23] Jian-zhong Wu,et al. Overexpression of KIF20A confers malignant phenotype of lung adenocarcinoma by promoting cell proliferation and inhibiting apoptosis , 2018, Cancer medicine.
[24] J. Vilo,et al. MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data. , 2018, Epigenomics.
[25] Chengfang Yao,et al. The paradoxical role of tumor-infiltrating immune cells in lung cancer. , 2017, Intractable & rare diseases research.
[26] Vladimir Gelfand,et al. Moonlighting Motors: Kinesin, Dynein, and Cell Polarity. , 2017, Trends in cell biology.
[27] Yingduan Cheng,et al. Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer , 2017, Oncotarget.
[28] Cheng Li,et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses , 2017, Nucleic Acids Res..
[29] P. Sicinski,et al. Cell cycle proteins as promising targets in cancer therapy , 2017, Nature Reviews Cancer.
[30] Andrew D. Rouillard,et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..
[31] Ahir Gopaldas. Therapy , 2016, Indian Journal of Nuclear Medicine : IJNM : The Official Journal of the Society of Nuclear Medicine, India.
[32] E. Uribe-Querol,et al. Neutrophils in Cancer: Two Sides of the Same Coin , 2015, Journal of immunology research.
[33] Yee Ming Lee,et al. The impact of the Cancer Genome Atlas on lung cancer. , 2015, Translational research : the journal of laboratory and clinical medicine.
[34] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[35] Tae-Min Kim,et al. Silencing of KIF14 interferes with cell cycle progression and cytokinesis by blocking the p27Kip1 ubiquitination pathway in hepatocellular carcinoma , 2014, Experimental & Molecular Medicine.
[36] X. J. Liu,et al. Xenopus oocyte meiosis lacks spindle assembly checkpoint control , 2013, The Journal of cell biology.
[37] H. Clarke,et al. Regulation of mitochondrial DNA accumulation during oocyte growth and meiotic maturation in the mouse. , 2012, Reproduction.
[38] Oliver Rath,et al. Kinesins and cancer , 2012, Nature Reviews Cancer.
[39] Sébastien Couraud,et al. Lung cancer in never smokers--a review. , 2012, European journal of cancer.
[40] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[41] Yue Yu,et al. The role of kinesin family proteins in tumorigenesis and progression , 2010, Cancer.
[42] Z. Szallasi,et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients , 2010, Breast Cancer Research and Treatment.
[43] N. Hirokawa,et al. Kinesin superfamily motor proteins and intracellular transport , 2009, Nature Reviews Molecular Cell Biology.
[44] L. Tanoue,et al. The new lung cancer staging system. , 2009, Chest.
[45] Ping Yang,et al. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. , 2008, Mayo Clinic proceedings.
[46] Bin Wang,et al. Conventional kinesin holoenzymes are composed of heavy and light chain homodimers. , 2008, Biochemistry.
[47] G A Colditz,et al. Comparison of aspects of smoking among the four histological types of lung cancer , 2008, Tobacco Control.
[48] T. Oshikiri,et al. Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma , 2006, British Journal of Cancer.
[49] F. Bray,et al. International lung cancer trends by histologic type: Male:Female differences diminishing and adenocarcinoma rates rising , 2005, International journal of cancer.
[50] Marina Bibikova,et al. Functional analysis of human microtubule-based motor proteins, the kinesins and dyneins, in mitosis/cytokinesis using RNA interference. , 2005, Molecular biology of the cell.
[51] Dennis B. Troup,et al. NCBI GEO: mining millions of expression profiles—database and tools , 2004, Nucleic Acids Res..
[52] N. Hirokawa,et al. Kinesin superfamily proteins and their various functions and dynamics. , 2004, Experimental cell research.
[53] P. Shannon,et al. Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks , 2003 .
[54] N. Hirokawa,et al. All kinesin superfamily protein, KIF, genes in mouse and human , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[55] G. C. Rogers,et al. Microtubule motors in mitosis , 2000, Nature.
[56] Peter A. Jones,et al. Cancer-epigenetics comes of age , 1999, Nature Genetics.
[57] N. Hirokawa,et al. Kinesin and dynein superfamily proteins and the mechanism of organelle transport. , 1998, Science.
[58] P. Laird. Oncogenic mechanisms mediated by DNA methylation. , 1997, Molecular medicine today.
[59] K. Kinzler,et al. Lessons from Hereditary Colorectal Cancer , 1996, Cell.
[60] Michael P. Sheetz,et al. Identification of a novel force-generating protein, kinesin, involved in microtubule-based motility , 1985, Cell.
[61] Yu Bai,et al. Co-expression network analysis identified KIF2C in association with progression and prognosis in lung adenocarcinoma. , 2019, Cancer biomarkers : section A of Disease markers.
[62] Susumu Goto,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..
[63] Supplemental Information 2: Kyoto Encyclopedia of genes and genomes. , 2022 .